[***] = Certain information that has been excluded from the exhibit because it is both not material and is the type that the registrant treats as private or confidential.

ARQ, INC.

EMPLOYMENT AGREEMENT

THIS AGREEMENT made and entered effective August 25, 2026 by and between Arq, Inc., a Delaware corporation, whose principal offices are located at 8051 E. Maplewood, Suite 210, Greenwood Village, CO 80111 (the “Company”), and Peter Owino (“Executive”) whose address is [***].

RECITALS:

WHEREAS, the Company has made Executive an offer of employment; and

WHEREAS, Executive desires to accept the offer;

WHEREAS, the Company and Executive desire to enter into this Agreement to set forth the terms and conditions of the employment.

NOW, THEREFORE in consideration of the premises and the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, hereby agree as follows:

1.Definitions. Capitalized terms are used herein with the meanings as specified in Section 5and elsewhere in this Employment Agreement.

2.Employment. The Company hereby employs Executive and Executive hereby accepts such employment upon the terms and conditions set forth herein, such employment to commence on or about September 1, 2026 (the “Start Date”). Executive’s employment with the Company is for an indefinite term, subject to termination as provided for in Section 7.

…

CONSULTING AGREEMENT

This Consulting Agreement (the “Agreement”) is made effective as of September 1, 2026 (the “Effective Date”), by and between Vyome Holdings, Inc., a Delaware corporation, with its principal place of business at Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138 (the “Company”) and ClearbridgeCFO, LLC, a limited liability company, with its principal place of business at 1349 W Peachtree Street NW, Ste. 1910, Atlanta, GA 30309 (“CLEARBRIDGE”) and Jerry Leonard, an individual (the “Consultant”). The Company, CLEARBRIDGE, and the Consultant are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”

WHEREAS, the Company is in the business of developing and commercial exploitation of novel therapies for treating immune-inflammatory and rare diseases.

WHEREAS, CLEARBRIDGE has expertise in CFO and other related services.

WHEREAS, CLEARBRIDGE desires to serve as an independent consultant for the purpose of providing the Company with CFO services, as more fully described in Annexure A attached hereto (the “Services”); and

WHEREAS, the Company wishes to engage CLEARBRIDGE on the terms and conditions set forth herein.

NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree and covenant as follows.

…

THIS INSTRUMENT AND ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED IN THIS SAFE AND UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.

SUNPOWER INC.

**SAFE **

(Simple Agreement for Future Equity)

THIS CERTIFIES THAT in exchange for the payment by the Rodgers Massey Revocable Living Trust dtd 4/4/11 (the “Investor”) of $2,000,000 (the “Purchase Amount”) on August 24, 2026, and SUNPOWER INC., a Delaware corporation (the “Company”), issues to the Investor the right to certain purchase Equity Securities of the Company, subject to the terms described below. See Section 2 for certain defined terms.

1. Events

…

August 26, 2026

Rainier Acquisition Corporation

1 Penn Plaza, 48th Floor

New York, NY 10119

Re: Initial Public Offering

Ladies and Gentlemen:

This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Rainier Acquisition Corporation, a Cayman Islands exempted company (the “Company”) and Chardan Capital Markets LLC, as representative (the “Representative”) of the underwriters named therein (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”) of up to 7,500,000 units of the Company (plus an additional 1,125,000 units that may be purchased pursuant to the Underwriters’ option to purchase additional units pursuant to the terms of the Underwriting Agreement), each such unit comprised of one Class A ordinary shares, par value $0.0001 per share (“Ordinary Shares”) and one-quarter of a redeemable warrant to purchase one Ordinary Share as provided for by the warrant agreement (the “Warrant Agreement”) to be entered into with Continental Stock Transfer & Trust Company, as warrant agent, in connection with the consummation of the Public Offering (such units, the “Public Units”). The Public Units will be sold in the Public Offering pursuant to a registration statement on Form S-1 and a prospectus (the “Prospectus”) filed by the Company with the U.S. Securities and Exchange Commission (the “Commission”). Certain capitalized terms used herein are defined

…

PRIVATE PLACEMENT UNIT PURCHASE AGREEMENT

THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of August 26, 2026, is entered into by and between Rainier Acquisition Corporation, a Cayman Islands exempted company (the “Company”), and Ravenna 7 LLC, a Delaware limited liability company (the “Purchaser”).

WHEREAS, the Company intends to consummate an initial public offering (the “Public Offering”) of the Company’s units (the “Public Units”), each such Public Unit comprised of one Class A ordinary share of the Company, par value $0.0001 per share and one-quarter of one redeemable warrant to purchase one Class A ordinary share to be governed by the Warrant Agreement to be entered into with Continental Stock Transfer & Trust Company in connection with the consummation of the Public Offering (the “Warrant Agreement”), as set forth in the Company’s Registration Statement on Form S-1, filed with the U.S. Securities and Exchange Commission (the “SEC”), File Number 333-298076 under the Securities Act of 1933, as amended (the “Securities Act”).

…

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of August 26, 2026, is made and entered into by and among Rainier Acquisition Corporation, a Cayman Islands exempted company (the “Company”), Ravenna 7 LLC, a Delaware limited liability company (the “Sponsor”), and each of the undersigned parties listed on the signature page (each such party, together with any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively, the “Holders”).

RECITALS

WHEREAS, the Sponsor and directors of the Company (the “Initial Holders”) currently own an aggregate of 2,156,250 shares of the Company’s Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”);

WHEREAS, the Class B Ordinary Shares are convertible into the Company’s Class A ordinary shares, par value $0.0001 per share (“Ordinary Shares”), at the time of the initial Business Combination or earlier at the option of the holder at a conversion ratio that results in the Initial Holders holding 20% of the outstanding ordinary shares on an as-converted basis (excluding seller earnout consideration and working capital conversion units), with a floor of one-for-one conversion, on the terms and conditions provided in the Company’s second amended and restated memorandum and articles of association, as may be amended from time to time;

…

INVESTMENT MANAGEMENT TRUST AGREEMENT

This Investment Management Trust Agreement (this “Agreement”) is made effective as of August 26, 2026 by and between Rainier Acquisition Corporation, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).

WHEREAS, the Company’s registration statement on Form S-1, File No. 333-298076 (the “Registration Statement”) and prospectus (the “Prospectus”) for the initial public offering of the Company’s units, each such public unit comprised of one Class A ordinary share, par value $0.0001 per share (“Ordinary Shares”) and one-quarter of a redeemable warrant to purchase one Class A ordinary share (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission; and

WHEREAS, the Company has entered into an Underwriting Agreement (the “Underwriting Agreement”) with Chardan Capital Markets LLC, as representative (the “Representative”) of the several underwriters (the “Underwriters”) named therein; and

…

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

**THIS AGREEMENT, **dated May 4, 2026 with an effective date of May 4, 2026 (the “Agreement”), is by and between Anavex Life Sciences Corp. (the “Company” or “Anavex”), and Terrie Kellmeyer, PhD (the “Employee”). The Company and the Employee are referred to each individually as a “Party” and collectively as the “Parties.”

RECITALS

** **

WHEREAS, the Parties executed that certain employment agreement dated September 13, 2023 and effective October 1, 2023 (the “Original Agreement”); and

WHEREAS, the Parties desire to amend and restate the Original Agreement as described below;

WHEREAS, the Company desires to employ and retain the Employee in order to advance the business and interests of the Company on the terms and conditions set forth herein; and

WHEREAS, the Employee wishes to be employed by the Company and desires to provide her services to the Company in such capacities, on and subject to the terms and conditions hereof; and

WHEREAS, the Company expends significant time and expense on an ongoing basis in supporting its employees, including the Employee; and

**WHEREAS, **the Company is clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer (the “Business”); and

…

AMENDMENT TO FINANCIAL PRODUCTS LICENSE AGREEMENT

This Amendment is entered into as of July 31st, 2026, by and between CF Benchmarks Ltd(“Licensor”), Bitwise Investment Advisers, LLC, (“BIA”) and Bitwise Investment Manager LLC, (“BIM” and together with BIA each a “Licensee”).

The Licensor and BIM entered into a Financial Product License Agreement on July 12th, 2023, as amended by the Variation Agreement on May 1st, 2024, October 27th, 2025, and October 29th, 2025 (the “Original Agreement”).

The Licensor and BIM, through this amendment agreement (the “Amendment Agreement”), wish to amend the Original Agreement by adding BIA as a third counterparty and by incorporating the changes set out below.

The amendments and additions contained herein shall have effect from July 10th, 2026 onwards, and shall supersede where applicable those contained in the Original Agreement

Except as expressly amended by this Amendment, all terms and conditions of the Agreement shall remain unchanged and in full force and effect. This Amendment shall be read and construed as one with the Agreement, and, in the event of any conflict, the terms of this Amendment shall prevail with respect to the subject matter herein.

…

AMENDMENT #2 TO THE COINBASE PRIME – EXCHANGE-TRADED PRODUCT (ETP) STAKING ADDENDUM

This Amendment #2 (this “Amendment”) dated as of August 27, 2026 (the “Effective Date”), to the Exchange-Traded Product (ETP) Staking Addendum, dated October 8, 2025, addendum to the Coinbase Custody Services Agreement dated July 29, 2023 as amended and restated from time to time (the “Original Addendum”), by and between Coinbase, Inc. (“Coinbase”), as agent for itself and for the Coinbase Entities and Bitwise Investment Advisers, LLC in its capacity as sponsor of the Funds (“Client”). Each Coinbase Entity and each Client may be individually referred to as a “Party” and collectively, the “Parties”.

WHEREAS, the Parties desire to amend the Original Addendum as set forth in this Amendment.

NOW THEREFORE, in consideration of the mutual agreement as set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, the Parties hereby agree as follows:

1. Defined Terms. Capitalized terms used in this Amendment and not defined herein shall have the meanings assigned to such terms in the Original Addendum.

2. Amendments. Annex A to the Original Addendum is hereby amended and restated in its entirety and replaced with the version of Annex A attached to this Amendment (the “Revised Annex A”). The Revised Annex A shall supersede and replace the previous Annex A for all purposes under the Original Addendum as of the Effective Date of this Amendment.

…

MARKETING AGENT AGREEMENT

THIS AGREEMENT is made and entered into as of February 2, 2026, and is effective as of December 31, 2025 (the “Effective Date”). This Agreement is by and between Bitwise Investment Advisers, LLC, a Delaware limited liability company in its capacity as sponsor to certain exchange-traded products (the “Sponsor”), for and on behalf of each applicable entity identified in Exhibit B hereto, severally and not jointly (each, a “Trust”) and Foreside Fund Services, LLC, a Delaware limited liability company (“ACA Foreside”).

WHEREAS, the Trust is a statutory trust organized under the laws of the State of Delaware;

WHEREAS, the Trust filed with the U.S. Securities and Exchange Commission (the “SEC”) a Registration Statement for the Trust under the Securities Act of 1933, as amended (the “1933 Act”);

WHEREAS, the Trust intends to create and redeem shares of beneficial interest in the Trust (the “Shares”) only in creation unit aggregations (“Creation Unit”) on a continuous basis, and list the Shares on one or more national securities exchanges;

WHEREAS, the Sponsor desires to retain ACA Foreside to provide certain services in connection with the offering of the Shares (as amended from time to time);

WHEREAS, ACA Foreside is registered as a broker-dealer under the Securities Exchange Act of 1934, as amended (the “1934 Act”), and is a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”);

WHEREAS, the Sponsor desires to retain ACA Foreside to provide certain services to the Trust; and

…

Date: _____________

Name:

Re: Retention Bonus

Dear [_______]:

DOOR Systems, Inc. (the “Company”) is pleased to offer you a special retention bonus in the amount of [$_______] (the “Bonus Amount”), to be paid to you provided you remain employed by the Company through December 31, 2027 (the “Vesting Date”).

This special bonus is in addition to all other compensation and benefits to which you are otherwise entitled and will not be treated as salary or “compensation” or taken into account for purposes of determining any other compensation or benefits that may be provided to you. As a condition to receiving the Bonus Amount, and subject to the paragraph below, you must remain employed in good standing with the Company or one of its affiliates through the Vesting Date. The Bonus Amount will be paid to you within forty-five (45) days following the Vesting Date, subject to applicable taxes and withholding.

A change of control or other corporate transaction involving the Company shall not, by itself, accelerate payment of the Bonus Amount. You must remain employed through the Vesting Date to earn the Bonus Amount, except as set forth in the following paragraph.

…